Sanofi to Close Irish Plant
ePT--the Electronic Newsletter of Pharmaceutical Technology
Paris (Mar. 15)-Sanofi-Aventis plans to close its manufacturing site in Waterford, Ireland.
Paris (Mar. 15)-Sanofi-Aventis (www.sanofi-aventis.com) plans to close its manufacturing site in Waterford, Ireland.
The company attributes the closure to increasing pressure from generics. Sanofi came to the decision after evaluating its plant network and concluding that other sites had excess capacity and could take over the manufacturing currently performed at the Waterford site with minimal extra investment.
The Waterford plant currently manufactures mature and over-the-counter products, including “Essentiale” for liver protection and “Flagyl” for microbial infections. Manufacture of these two products will be taken over by Sanofi plants in France and Germany.
The site is expected to close by the end of the year, with the loss of about 200 jobs.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Telix Enters Agreement with ImaginAb to Purchase Next-Gen Therapeutic Candidates
Published: January 13th 2025 | Updated: January 13th 2025The transaction adds a pipeline of early-stage drug candidates against high-value targets to Telix’s portfolio, along with other novel targets currently in the discovery stage.
